AD

2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato(CAS: 1367369-79-6)

2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato
CAS Number

Related Products

Other Suppliers for 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato

Basic Information

Molecular Formula
C12H15N5O3
Molecular Weight
277.28 g/mol

Physical Properties

Boiling Point
661.4±65.0 °C(Predicted)
Density
1.81±0.1 g/cm3(Predicted)

Chemical Identifiers

SMILES
C=C1C(CC(C1CO)O)n2cnc3c2[nH]c(nc3=O)N
InChIKey
QDGZDCVAUDNJFG-UHFFFAOYSA-N

Database References

MDL Number
MFCD31562807

FAQ

The compound 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato (CAS: 1367369-79-6) falls under the purine derivatives category and is subject to various safety and environmental regulations. It may require registration under the REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) regulations in the EU. In the United States, it may also be regulated by the EPA under OSHA (Occupational Safety and Health Act) and DOT (Department of Transportation) for transportation and storage. It is advisable to consult the Material Safety Data Sheet (MSDS) for specific handling and disposal guidelines.
There are several alternatives to 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato (CAS: 1367369-79-6) in synthesis, including purine analogs like theophylline, hypoxanthine, and adenine. These compounds can serve as effective substitutes depending on the specific requirements of the reaction. Common alternative reagents include purine nucleosides and their derivatives, which can be used in similar contexts.
The market for 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato (CAS: 1367369-79-6) is currently limited, but there is a growing interest in its potential applications in pharmaceuticals, particularly for its role in nucleoside-based therapies. Research trends indicate an increasing focus on developing new purine analogs for drug discovery and treatment of conditions such as cancer and viral infections. The trend towards personalized medicine and targeted drug delivery is expected to drive further research interest in this compound.
Waste containing 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-onato (CAS: 1367369-79-6) should be managed according to the waste disposal guidelines specified in the MSDS. It is crucial to ensure that waste is collected in appropriate containers and disposed of through a licensed hazardous waste facility. For liquid waste, it should be collected in sealed containers and treated according to local regulations. Incineration or professional waste disposal services may be necessary to ensure that the waste is handled safely and environmentally responsibly. Proper labeling and documentation are also essential to comply with regulatory requirements.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Contact Person

Tang Silei

Email

2881489226@qq.com

Mobile

15026964105

Telephone

15026964105

Fax

021-55068248

Address

No. 6 Building, 465 Changta Road, Songjiang District, Shanghai